Aurora Cannabis (TSE:ACB – Get Free Report) has been assigned a C$9.00 price objective by research analysts at TD Securities in a research note issued on Wednesday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. TD Securities’ price target points to a potential upside of 48.76% from the company’s previous close.
Aurora Cannabis Stock Performance
Shares of Aurora Cannabis stock opened at C$6.05 on Wednesday. The firm’s fifty day simple moving average is C$6.99 and its 200-day simple moving average is C$7.63. Aurora Cannabis has a 12 month low of C$3.84 and a 12 month high of C$12.85. The stock has a market capitalization of C$330.69 million, a price-to-earnings ratio of -9.60 and a beta of 2.71. The company has a debt-to-equity ratio of 16.95, a current ratio of 3.76 and a quick ratio of 2.48.
Insider Transactions at Aurora Cannabis
In other news, Senior Officer Andre Jerome sold 7,712 shares of the company’s stock in a transaction that occurred on Monday, September 23rd. The stock was sold at an average price of C$7.70, for a total transaction of C$59,382.40.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.
See Also
- Five stocks we like better than Aurora Cannabis
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Canadian Penny Stocks: Can They Make You Rich?
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.